A Conversation with Dr. Stephan Urban, Who Developed the First Drug for hepatitis D

This is a special edition episode - Ed Tate, Director of Communications at the Hepatitis B Foundation was able to sit down with Dr. Stephan Urban the developer of the hepatitis D drug, Hepcludex. The drug, which blocks the entry of the hepatitis B and hepatitis D virus into the liver cell, was approved by the European Commission on 31 July 2020. Listen for more of their conversation. Consider donating here to support programs like B Heppy! Questions? Send them to: [email protected]...